H.R. 1026 · 117th Congress · House

LABEL Opioids Act

Active· Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Introduced
Feb 11, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act

This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.

Action Timeline

6
  1. APR 28, 2021•Committee

    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

  2. FEB 12, 2021•Committee

    Referred to the Subcommittee on Health.

  3. FEB 11, 2021•IntroReferral

    Introduced in House

  4. FEB 11, 2021•IntroReferral

    Introduced in House

  5. FEB 11, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. FEB 11, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

4

Crime and Federal Government Surveillance Subcommittee

hsju08

Referred: Apr 28, 2021

Active

Health Subcommittee

hsif14

Referred: Feb 12, 2021

Active

Judiciary Committee

hsju00

Referred: Feb 11, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Feb 11, 2021

Active